These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2407242)

  • 1. Inhibition of Trypanosoma cruzi growth and sterol biosynthesis by lovastatin.
    Florin-Christensen M; Florin-Christensen J; Garin C; Isola E; Brenner RR; Rasmussen L
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1441-5. PubMed ID: 2407242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Lazardi K; Marchan E; Visbal G; Aguirre T; Piras MM; Piras R; Maldonado RA; Payares G; de Souza W
    Antimicrob Agents Chemother; 1993 Mar; 37(3):580-91. PubMed ID: 8460926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity, pharmacological inhibition and biological regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in Trypanosoma brucei.
    Coppens I; Bastin P; Levade T; Courtoy PJ
    Mol Biochem Parasitol; 1995 Jan; 69(1):29-40. PubMed ID: 7723786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole.
    Urbina JA; Vivas J; Visbal G; Contreras LM
    Mol Biochem Parasitol; 1995 Jul; 73(1-2):199-210. PubMed ID: 8577328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi response to sterol biosynthesis inhibitors: morphophysiological alterations leading to cell death.
    Kessler RL; Soares MJ; Probst CM; Krieger MA
    PLoS One; 2013; 8(1):e55497. PubMed ID: 23383204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro.
    Goad LJ; Berens RL; Marr JJ; Beach DH; Holz GG
    Mol Biochem Parasitol; 1989 Jan; 32(2-3):179-89. PubMed ID: 2494453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of a plant sesquiterpene cyclase by mevinolin.
    Vögeli U; Chappell J
    Arch Biochem Biophys; 1991 Jul; 288(1):157-62. PubMed ID: 1898013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine inhibits cyclization of squalene oxide to lanosterol in mammalian cells.
    Chen HW; Leonard DA
    J Biol Chem; 1984 Jul; 259(13):8156-62. PubMed ID: 6429139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi epimastigotes.
    Beach DH; Goad LJ; Holz GG
    Biochem Biophys Res Commun; 1986 May; 136(3):851-6. PubMed ID: 3521598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activities of 3-hydroxyl-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and the rate of mevalonic acid, squalene, sterol and fatty acid biosynthesis from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: effects of Triton WR 1339, starvation and cholesterol diet].
    Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
    Biokhimiia; 1981 Feb; 46(2):296-305. PubMed ID: 6113854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activities of 3-hydroxy-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and rate of biosynthesis of mevalonic acid, squalene, sterols and fatty acids from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: changes induced by daily rhythm].
    Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
    Biokhimiia; 1981 Jan; 46(1):126-39. PubMed ID: 6113851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for rate-limiting steps in sterol synthesis beyond 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human leukocytes.
    Burns CP; Welshman IR; Edmond J; Spector AA
    Biochim Biophys Acta; 1979 Feb; 572(2):345-51. PubMed ID: 427182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosome sterols and their metabolic origins.
    Dixon H; Ginger CD; Williamson J
    Comp Biochem Physiol B; 1972 Jan; 41(1):1-18. PubMed ID: 4561635
    [No Abstract]   [Full Text] [Related]  

  • 14. Sterol composition and biosynthesis in Trypanosoma cruzi amastigotes.
    Liendo A; Visbal G; Piras MM; Piras R; Urbina JA
    Mol Biochem Parasitol; 1999 Oct; 104(1):81-91. PubMed ID: 10589983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.
    Urbina JA; Concepcion JL; Rangel S; Visbal G; Lira R
    Mol Biochem Parasitol; 2002; 125(1-2):35-45. PubMed ID: 12467972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-244 specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A synthase.
    Tomoda H; Kumagai H; Tanaka H; Omura S
    Biochim Biophys Acta; 1987 Dec; 922(3):351-6. PubMed ID: 2891379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors.
    Bocan TM; Ferguson E; McNally W; Uhlendorf PD; Bak Mueller S; Dehart P; Sliskovic DR; Roth BD; Krause BR; Newton RS
    Biochim Biophys Acta; 1992 Jan; 1123(2):133-44. PubMed ID: 1739744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteroallyl-containing 5-nitrofuranes as new anti-Trypanosoma cruzi agents with a dual mechanism of action.
    Gerpe A; Odreman-Nuñez I; Draper P; Boiani L; Urbina JA; González M; Cerecetto H
    Bioorg Med Chem; 2008 Jan; 16(1):569-77. PubMed ID: 17981471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors.
    Buckner FS; Griffin JH; Wilson AJ; Van Voorhis WC
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1210-5. PubMed ID: 11257036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.